Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation
Status:
Completed
Trial end date:
2017-06-14
Target enrollment:
Participant gender:
Summary
A prospective, multicenter, open-label, randomized and parallel-group clinical trial was
conducted at four transplant centers in Korea. This clinical study was designed to compare
the efficacy and tolerability of reduced-dose tacrolimus with standard-dose mycophenolate
mofetil (MMF) versus standard-dose tacrolimus with reduced-dose MMF.